Usefulness of echocardiography to detect cardiac involvement in COVID‐19 patients
Autor: | Federico Franchi, Giulia Elena Mandoli, Maria Concetta Pastore, Sergio Mondillo, Flavio D'Ascenzi, Matteo Cameli, Hatem Soliman Aboumarie, Serafina Valente, E. Bigio, Paolo Cameli |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Heart Injury SARS‐CoV2 Heart Diseases Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) medicine.medical_treatment Reviews heart failure Review Disease 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine COVID‐19 Internal medicine Humans Medicine myocardial injury Radiology Nuclear Medicine and imaging 030212 general & internal medicine Mechanical ventilation business.industry COVID-19 Reproducibility of Results Emergency department medicine.disease echocardiography myocarditis SARS-CoV2 Acute myocarditis Echocardiography Radiology Nuclear Medicine and imaging Heart failure Cardiology Cardiology and Cardiovascular Medicine business |
Zdroj: | Echocardiography Echocardiography (Mount Kisco, N.y.) |
ISSN: | 1540-8175 0742-2822 |
DOI: | 10.1111/echo.14779 |
Popis: | Coronavirus disease 2019 (COVID‐19) outbreak is a current global healthcare burden, leading to the life‐threatening severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, evidence showed that, even if the prevalence of COVID‐19 damage consists in pulmonary lesions and symptoms, it could also affect other organs, such as heart, liver, and spleen. Particularly, some infected patients refer to the emergency department for cardiovascular symptoms, and around 10% of COVID‐19 victims had finally developed heart injury. Therefore, the use of echocardiography, according to the safety local protocols and ensuring the use of personal protective equipment, could be useful firstly to discriminate between primary cardiac disease or COVID‐19–related myocardial damage, and then for assessing and monitoring COVID‐19 cardiovascular complications: acute myocarditis and arrhythmias, acute heart failure, sepsis‐induced myocardial impairment, and right ventricular failure derived from treatment with high‐pressure mechanical ventilation. The present review aims to enlighten the applications of transthoracic echocardiography for the diagnostic and therapeutic management of myocardial damage in COVID‐19 patients. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |